Tecaginlimab (BNT-312) is an Fc-inert bispecific antibody engineered for the dual targeting and conditional stimulation of CD40 and 4-1BB receptors. This antibody is designed to enhance the priming and reactivation of tumor-specific immune responses, making it a valuable tool for research in cancer immunotherapy. Tecaginlimab's unique ability to engage both CD40 and 4-1BB under specific conditions allows for precise modulation of immune activation, potentially leading to improved therapeutic outcomes in oncology research.
Tecaginlimab (BNT-312) is an Fc-inert bispecific antibody engineered for the dual targeting and conditional stimulation of CD40 and 4-1BB receptors. This antibody is designed to enhance the priming and reactivation of tumor-specific immune responses, making it a valuable tool for research in cancer immunotherapy. Tecaginlimab's unique ability to engage both CD40 and 4-1BB under specific conditions allows for precise modulation of immune activation, potentially leading to improved therapeutic outcomes in oncology research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
